This study seeks to evaluate the integrated (e.g, energy expenditure) and organ specific thyromimetic responses (e.g., liver, bone and heart) to treatment with tiratricol and L-thyroxine. Also to evaluate the optimal dose, administration regimen and efficacy of TSH suppression therapy with tiratricol to be used in subsequent blinded clinical trials.
Showing the most recent 10 out of 65 publications